Miltenyi Biomedicine
Miltenyi Biomedicine is a biopharmaceutical company whose mission is to bring accessible and innovative cancer treatments and regenerative therapies to patients.
We strive to make a difference for patients who fight serious diseases every day – to improve their quality of life and give them the chance to live fully and create new dreams.
Building on Miltenyi’s decades of experience, we are uniquely positioned to realize the great potential of the new cell and gene therapies and make them available to patients worldwide. Both Miltenyi Biomedicine and Miltenyi Biotec were founded and are privately owned by Stefan Miltenyi who is advancing cellular therapy since 1989.
